News
DEA Guidance Regarding Information Pharmacists May Provide on CS II Prescriptions
Recognizing that pharmacists are sometimes presented with prescriptions for Schedule II controlled substances that are missing information required by law, Drug Enforcement Administration provides guidance for pharmacists regarding allowed changes or additions to such prescriptions.
Read More →Nominations for 2014 NABP Annual Awards Now Being Accepted
NABP invites you to nominate a colleague or board of pharmacy for a 2014 NABP award.
Read More →ASHP Joins NABP and APhA to Partner in Leadership of Center for Pharmacy Practice Accreditation
The American Society of Health-System Pharmacists (ASHP) has joined the governance body of the Center for Pharmacy Practice Accreditation (CPPA).
FDA Approves New Flu Vaccines Produced Using New Technologies
FDA has approved two new flu vaccines that, instead of using eggs to grow the influenza virus, use cell lines from either a mammal or insects.
FDA Committee Recommends Schedule II Classification for Drugs Containing Hydrocodone
The Food and Drug Administration (FDA) Drug Safety and Risk Management Advisory Committee recommended reclassifying hydrocodone combination products as Schedule II controlled substances after a two-day meeting.
NABP PMP InterConnect Processes One Millionth Request, Assists in Preventing Prescription Drug Abuse and Diversion
NABP PMP InterConnect®, the system that facilitates the secure transfer of prescription monitoring program (PMP) data across state lines to authorized users, continues to help prevent the diversion and abuse of prescription drugs.
Providers Should Ensure Only Diluted Forms of Acetic Acid are Used, ISMP Warns
The Institute for Safe Medication Practices (ISMP) has issued a National Alert Network (NAN) notice (PDF) advising that health care organizations should take immediate steps to ensure that only diluted acetic acid solutions are used in patient care.
Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
The National Association of Boards of Pharmacy® (NABP®) today issued a report outlining how continued collaboration among global stakeholders is vital to eliminating the public health threats posed by rogue Internet drug outlets.
Tennessee Task Force Reviews State’s Compounding Pharmacy Regulations
The Tennessee Board of Pharmacy has convened a task force to review the state’s regulations pertaining to compounding and determine how regulations might be strengthened to further protect the public health.
Massachusetts Close to Completing Surprise Inspections of Compounding Pharmacies, FDA Joins Investigation of One Pharmacy
Bureau of Health Care Safety and Quality inspectors in Massachusetts are close to completing a round of surprise inspections of compounding pharmacies and FDA inspectors have also begun inspecting one of the pharmacies.
USP Seeks Candidates for Expert Panel on General Chapter <797> Pharmaceutical Compounding – Sterile Preparations
USP is seeking qualified candidates to serve on the Pharmaceutical Compounding–Sterile Preparations Expert Panel.
Canadian Citizen Sentenced to Four Years for Role in Internet Drug Outlet Operation
Andrew J. Strempler, a Canadian citizen, was sentenced to four years in prison for charges related to the operation of a Web site illegally marketing and distributing prescription drugs to US residents.
New York City Hospitals to Follow New Prescribing Guidelines Intended to Reduce Abuse of Painkillers
To help reduce abuse and overdoses of prescription pain medications, New York City public hospitals will begin following new voluntary guidelines on prescribing.
Texas Board Surveys Pharmacies About Compounding Practices, Will Seek Legislative Support for Additional Inspectors
In the wake of the meningitis outbreak linked to contaminated drugs compounded by the New England Compounding Center (NECC), the Texas State Board of Pharmacy conducted a special survey.
Rx Response Offers Support for Areas Affected By Flu Outbreak
A spike in flu activity and limited supplies of vaccine and Tamiflu® doses across the country have prompted Rx Response to move its operations to Alert status.
FDA Issues New Guidelines for Sleep Aids Containing Zolpidem
FDA has issued new dosing recommendations for sleep aids containing zolpidem.
ISMP Launches Program to Track Vaccine Errors With Aim to Protect Patient Safety
The Institute for Safe Medication Practices (ISMP) has launched a National Vaccine Error Reporting Program (VERP) that allows health care providers to confidentially report vaccine administration errors and near misses.
Difference In Generic Pills’ Color May Affect Patient's Adherence
Patients refilling prescriptions who receive pills of a different color than for a previous prescription may be less likely to adhere to their drug therapy.
Minnesota Board Implements Plan to Strengthen Regulation of Compounding Pharmacies
The Minnesota Board of Pharmacy, which already has strong compounding regulations and requirements in place, is in the process of considering additional requirements, some of which will require the passage of new legislation.
California Board of Pharmacy Sponsors Legislation Authorizing Inspection of Nonresident Compounding Pharmacies
The California State Board of Pharmacy will sponsor a bill that would allow inspectors to make unannounced on-site inspections of certain nonresident pharmacies.
Massachusetts Governor Patrick Files Bill to Strengthen State’s Regulation of Compounding Pharmacies
Massachusetts Governor Deval Patrick will file a bill that would strengthen the state’s regulation of compounding pharmacies.
ASOP and Google Help Warn Consumers About Online Dangers; European Partners Join ASOP Efforts
Google has begun running search-based advertising aimed to help educate US consumers about illegal online drug sellers.
NABP to Implement Five-Attempt Limit for NAPLEX, MPJE
Effective March 1, 2013, candidates will be limited to five attempts to pass the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE).
FDA Warns Doctors About Unapproved Drug Products, Including Botox, Purchased from Foreign Suppliers
Emphasizing risks to patient safety, Food and Drug Administration (FDA) has alerted more than 350 medical practices (PDF) across the country that they may have received unapproved medications.
FDA to Hold Public Hearing on Use of Opioid Pain Medications
As FDA continues to seek a balance between minimizing opioid drug abuse and enabling the appropriate treatment of pain, the agency will hold a two-day public hearing to obtain information.
2013 NABP Survey of Pharmacy Law Now Available
The updated 2013 Survey of Pharmacy Law is now available
Oregon State Board of Pharmacy and LegitScript Take Actions to Stymie Rogue Internet Drug Outlets
The Oregon State Board of Pharmacy and LegitScript took actions to prevent rogue Internet drug outlets from distributing products.
Study Examines EHR-Related Patient Safety Events, Including Medication Errors
In a new study analyzing electronic health record (EHR)-related patient safety events, the majority of events involved medication errors.